Evidence map›Paper›PMID 38793793›Full record

ArticleVaccines2024

Selecting and Tailoring Implementation Strategies to Improve Human Papillomavirus Vaccine Uptake in Zambia: A Nominal Group Technique Approach.

Mwansa Ketty Lubeya, Mulindi Mwanahamuntu, Carla J Chibwesha, Moses Mukosha, Mary Kawonga

Abstract read
In one paragraph

Article in Vaccines, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed.

  1. Review
  2. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors.

Mwansa Ketty LubeyaDepartment of Obstetrics and Gynaecology, School of Medicine, University of Zambia, Lusaka 10101, Zambia.ORCID 0000-0002-8526-3410
Mulindi MwanahamuntuDepartment of Obstetrics and Gynaecology, School of Medicine, University of Zambia, Lusaka 10101, Zambia.ORCID 0000-0001-6378-0276
Carla J ChibweshaClinical HIV Research Unit, Helen Joseph Hospital, Johannesburg 2193, South Africa.
Moses MukoshaSchool of Public Health, Faculty of Health Sciences, University of the Witwatersrand, Johannesburg 2017, South Africa.
Mary KawongaSchool of Public Health, Faculty of Health Sciences, University of the Witwatersrand, Johannesburg 2017, South Africa.ORCID 0000-0001-9807-7847

Funding

The UNC-UNZA-Wits Partnership for HIV and Women's Reproductive HealthD43TW010558 · FIC · UNIV OF NORTH CAROLINA CHAPEL HILL · PI CHI, BENJAMIN H., CHIBWESHA, CARLA J · 2017 to 2021
$1.5M
FIC NIH HHS D43 TW010558
6 · The paper itself

Abstract

The human papillomavirus (HPV) vaccine is effective in cervical cancer prevention. However, many barriers to uptake exist and strategies to overcome them are needed. Therefore, this study aimed to select and tailor implementation strategies to barriers identified by multiple stakeholders in Zambia. The study was conducted in Lusaka district between January and February 2023. Participants were purposively sampled from three stakeholder groups namely, adolescent girls, parents, and teachers and healthcare workers. With each of the stakeholders' groups (10-13 participants per group), we used the nominal group technique to gain consensus to tailor feasible and acceptable implementation strategies for mitigating the identified contextual barriers. The identified barriers included low levels of knowledge and awareness about the HPV vaccine, being out of school, poor community sensitisation, lack of parental consent to vaccinate daughters, and myths and misinformation about the HPV vaccine. The lack of knowledge and awareness of the HPV vaccine was a common barrier across the three groups. Tailored strategies included conducting educational meetings and consensus-building meetings, using mass media, changing service sites, re-examining implementation, and involving patients/consumers and their relatives. Our study contributes to the available evidence on the process of selecting and tailoring implementation strategies to overcome contextual barriers. Policymakers should consider these tailored strategies to mitigate barriers and improve HPV vaccine uptake.

Indexed as

acceptabilitybarrierscervical cancer eliminationfeasibilityimplementation strategiesknowledgemyths and misconceptionsZambia

Identifiers

PMID38793793
PMCPMC11126122

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.